Boston Scientific Corporation (ticker: BSX, exchange: New York Stock Exchange (.N))
News Release -
Boston Scientific Announces Election of Kristina Johnson and Nancy-Ann DeParle to the Board of Directors
NATICK, Mass., April 26 /PRNewswire-FirstCall/ -- Boston Scientific
Corporation (NYSE: BSX) today announced that the company's Board of Directors
elected Kristina M. Johnson, Ph.D. and Nancy-Ann DeParle as Directors. Dr.
Johnson and Ms. DeParle were members of the board of directors of Guidant
Corporation, which was acquired by the company last week. With the election
of Dr. Johnson and Ms. DeParle, the Boston Scientific Board increases from 12
to 14 members.
Kristina M. Johnson, 48, is the Dean of the Pratt School of Engineering at
Duke University, a position she has held since 1999. Previously, she served
as a professor in the Electrical and Computer Engineering Department,
University of Colorado and director of the National Science Foundation
Engineering Research Center for Optoelectronics Computing Systems at the
University of Colorado, Boulder. Dr. Johnson is a co-founder of the Colorado
Advanced Technology Institute Center of Excellence in Optoelectronics and
serves as a director of Minerals Technologies, Inc. and AES Corporation. Dr.
Johnson was a Fulbright Faculty Scholar in the Department of Electrical
Engineering at the University of Edinburgh, Scotland, and a NATO Post-Doctoral
Fellow at Trinity College, Dublin, Ireland. Dr. Johnson received B.S., M.S.
and Ph.D. degrees in electrical engineering from Stanford University.
Nancy-Ann DeParle, 49, is a Senior Advisor for JP Morgan Partners, LLC,
and an Adjunct Professor at The Wharton School of the University of
Pennsylvania. Previously, she served as the Administrator of the Health Care
Financing Administration (HCFA) (now the Centers for Medicare and Medicaid
Services). Prior to her role at HCFA, Ms. DeParle was the Associate Director
for Health and Personnel at the White House Office of Management and Budget
and served as commissioner of the Tennessee Department of Human Services. Ms.
DeParle is a director of Cerner Corporation, DaVita Inc. and Triad Hospitals,
Inc. She is also a trustee of the Robert Wood Johnson Foundation and serves
on the Medicare Payment Advisory Commission. Ms. DeParle received a B.A.
degree from the University of Tennessee, a J.D. from Harvard Law School, and
B.A. and M.A. degrees in Politics and Economics from Balliol College of Oxford
University, where she was a Rhodes Scholar.
"We are very pleased to welcome Kristina and Nancy-Ann to Boston
Scientific," said Pete Nicholas, Chairman of the Boston Scientific Board of
Directors. "Their leadership, intellect and years of experience will be
extremely valuable to our company, especially as we begin our combination with
Guidant. They are people of exceptional capability and achievement, and we
are honored to have them join Boston Scientific at such a momentous time in
The new Board members were elected as of April 24, the first business day
after the closing of the Guidant acquisition. They have each been nominated
for re-election at the company's annual meeting of stockholders on May 9,
Boston Scientific is a worldwide developer, manufacturer and marketer of
medical devices whose products are used in a broad range of interventional
medical specialties. For more information, please visit:
This press release contains forward-looking statements. Boston Scientific
wishes to caution the reader of this press release that actual results may
differ from those discussed in the forward-looking statements and may be
adversely affected by, among other things, risks associated with new product
development and commercialization, clinical trials, intellectual property,
regulatory approvals, competitive offerings, integration of acquired
companies, Boston Scientific's overall business strategy, and other factors
described in Boston Scientific's filings with the Securities and Exchange
CONTACT: Milan Kofol
Boston Scientific Corporation
Boston Scientific Corporation
SOURCE Boston Scientific Corporation
CONTACT: Milan Kofol, Investor Relations, +1-508-650-8569, or Paul
Donovan, Media Relations, +1-508-650-8541, both of Boston Scientific
Web site: http://www.bostonscientific.com